文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Complementary and alternative medicine use in migraine patients: results from a national patient e-survey.

作者信息

Makarevičius Gytis, Dapkutė Austėja, Ryliškienė Kristina

机构信息

Center of Neurology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

出版信息

Front Neurol. 2024 May 28;15:1378532. doi: 10.3389/fneur.2024.1378532. eCollection 2024.


DOI:10.3389/fneur.2024.1378532
PMID:38863511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11165229/
Abstract

OBJECT: This cross-sectional study aims to investigate migraineurs' preferred complementary and alternative medicine (CAM) types and the factors influencing their usage. MATERIALS AND METHODS: An anonymous e-survey was distributed to Lithuanian Migraine Association members, and social media migraine support communities. The collected data consisted of demographic, migraine-related questions, personal qualities, CAM habits. RESULTS: 470 respondents were analyzed. 95.96% were women with a median age of 37 (IQR 31, 44). The median duration of migraine was 17.5 years (IQR 10, 25) and the median headache severity was rated 8 (IQR 7, 10) out of 10. 68.90% of participants had one or more headache days per week. 71.49% of respondents were triptan users, 27.66% used medical prophylaxis, and 17.87% used monoclonal antibodies. 52.55% of respondents used CAM in the past 12 months. Physical activity (36.17%), dietary changes/fasting (27.02%), relaxation/meditation (26.60%) were the most used CAM types. Reasons for CAM use included dissatisfaction with conventional treatment effectiveness (42.51%), concerns about safety (48.18%) and adverse effects (37.25%). Factors associated with the decision to explore CAM included longer headache duration ( = 0.017, Mann-Whitney U test), frequent sick leaves ( < 0.001, Mann-Whitney U test), current preventive medication use ( = 0.016, chi-square test), positive views on CAM safety/naturality ( = 0.001/  < 0.001, Mann-Whitney U test), belief of having a healthy diet (p < 0.001, chi-square test), food-related worries ( = 0.011, Mann-Whitney U test) and Big-five personality trait of openness to experience ( = 0.049, chi-square test). After logistic regression, the frequent need to take sick leaves, having a healthy diet, food-associated fears maintained statistical significance. CAM use was not associated with non-adherence to conventional medicine. 48.99% of CAM consumers disclosed CAM use to their doctors. CONCLUSION: CAM is explored by a significant proportion of migraineurs, less than half communicate this to their doctors. In our sample, physical activity, dietary changes, and relaxation techniques were the most common. Many patients opted for CAM due to previously experienced side effects/ineffectiveness of conventional migraine treatment or the fear of potential harm from standard medication. Individual factors, such as openness of personality can be an important contributing factor.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/11165229/a4463764173f/fneur-15-1378532-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/11165229/346f2f84daca/fneur-15-1378532-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/11165229/a4463764173f/fneur-15-1378532-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/11165229/346f2f84daca/fneur-15-1378532-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b91/11165229/a4463764173f/fneur-15-1378532-g002.jpg

相似文献

[1]
Complementary and alternative medicine use in migraine patients: results from a national patient e-survey.

Front Neurol. 2024-5-28

[2]
Does complementary and alternative medicine (CAM) use reduce negative life impact of headaches for chronic migraineurs? A national survey.

Springerplus. 2016-7-7

[3]
Complementary and Alternative Medicine Use Among US Adults With Headache or Migraine: Results from the 2012 National Health Interview Survey.

Headache. 2017-9

[4]
Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy.

Cephalalgia. 2005-7

[5]
The Association between Chronicity of Migraine and Complementary and Alternative Medication Use: The Turkish Perspective.

Eur Neurol. 2019-4-23

[6]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[7]
The Use of Complementary and Alternative Medicine among Peritoneal Dialysis Patients at a Second-Level Hospital in Yucatán Mexico.

Healthcare (Basel). 2023-3-1

[8]
Knowledge, attitude, perceived effectiveness and self-practice of complementary and alternative medicine: a cross-sectional comparison between medical and non-medical students of Bangladesh.

BMC Complement Med Ther. 2022-12-28

[9]
A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthy.

Headache. 2013-6-14

[10]
The Prevalence of Complementary and Alternative Medicine Use among Dermatologic Outpatients in Shiraz, Iran.

Iran J Med Sci. 2016-5

本文引用的文献

[1]
Alternative medicine therapies in neurological disorders: Prevalence, reasons and associated factors. A systematic review.

Complement Ther Med. 2023-5

[2]
COVID-19 pandemic: Impact of quarantine on migraine and patients' care in Lithuania.

Clin Neurol Neurosurg. 2023-3

[3]
Alternative and complementary medicine in neurological disorders and neurological disability patients: Prevalence, factors, opinions and reasons.

Complement Ther Med. 2023-3

[4]
Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence.

Front Neurol. 2022-5-30

[5]
Traditional and Medical Applications of Fasting.

Nutrients. 2022-1-19

[6]
Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study.

Headache. 2021-11

[7]
Chronic Stress, Exercise and Cardiovascular Disease: Placing the Benefits and Risks of Physical Activity into Perspective.

Int J Environ Res Public Health. 2021-9-21

[8]
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.

Cephalalgia. 2022-1

[9]
The Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Versus Longer-Term Limitations.

Nutrients. 2021-4-3

[10]
Migraine: integrated approaches to clinical management and emerging treatments.

Lancet. 2021-4-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索